Clinical trials: Migrainous Vertigo
Vestibular Migraine
Effects of Lifestyle Modification on Vestibular Migraine
Vestibular migraine was recently addressed by the International Headache Society (IHS) as separate from other types of migraine. Vestibular migraine is one of the most common causes of vertigo attacks, affecting 1-5% of people.
- Trial name
- LMVM (NCT03979677)
- Testing
- Lifestyle Modifications
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University Medical Center
Migraine Disorders
Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine
The investigators' study plans to randomize treatment naive patients with vestibular migraine to an 8 week trial of an escalating dose of either nortriptyline or topiramate followed by an 8 week crossover to the other drug if…
- Trial name
- NCT02169830
- Testing
- nortriptyline, Topiramate, Diet Modification
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- St. Louis University
Vestibular Migraine, Migrainous Vertigo
Rizatriptan for Episodic Dizziness in Vestibular Migraine
Suffering from dizzy spells and migraine headaches? Vestibular Migraine (VM), a newly recognized type of migraine that causes bouts of dizziness.
- Trial name
- NCT02447991
- Testing
- Rizatriptan
- Where
- 3 sites in United States
- Volunteers
- 223 people
- Sponsor
- Robert W. Baloh
Vestibular Migraine
Galcanezumab for Vestibular Migraine
Vestibular migraine (VM) has been recognized a distinct subtype of migraine that causes dizziness as the predominant symptom. Criteria for diagnosis have been adopted by the Barany Society.
- Trial name
- NCT04417361
- Testing
- Galcanezumab Prefilled Syringe
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, San Francisco